Skip to main content
Surfactant function and composition in premature infants treated with inhaled nitric oxide.
Management guidelines for mucopolysaccharidosis VI.
Cost-effectiveness of alternative strategies for tuberculosis screening before kindergarten entry.
Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity.
Determinants of outcomes after head cooling for neonatal encephalopathy.
Kernicterus, the Daubert decision, and evidence-based medicine.
Health insurance across vulnerable ages: patterns and disparities from adolescence to the early 30s.
Brain abnormalities in patients with hyperimmunoglobulin E syndrome.
Inflammatory markers and mediators in tracheal fluid of premature infants treated with inhaled nitric oxide.
Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging.